EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles

Shubham Joshi iD, Sarah Allabun iD, Stephen Ojo iD, Mohammed S Alqahtani iD, Piyush Kumar Shukla iD, Mohamed Abbas iD, Chitapong Wechtaisong, Hussain M Almohiy

Molecules · 24.02.2023 · 28 (5) · 2130

DOI: 10.3390/molecules28052130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 24.02.2023. Verfasst von Shubham Joshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Engineering, SVKM'S NMIMS Mukesh Patel School of Technology Management and Engineering, Shirpur 425405, Maharashtra, India. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Nanoparticles. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University, King Khalid University (KKU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells (MSCs) have newly developed as a potential drug delivery system. MSC-based drug delivery systems (MSCs-DDS) have made significant strides in the treatment of several illnesses, as shown by a plethora of research. However, as this area of research rapidly develops, several issues with this delivery technique have emerged, most often as a result of its intrinsic limits. To increase the effectiveness and security of this system, several cutting-edge technologies are being developed concurrently. However, the advancement of MSC applicability in clinical practice is severely hampered by the absence of standardized methodologies for assessing cell safety, effectiveness, and biodistribution. In this work, the biodistribution and systemic safety of MSCs are highlighted as we assess the status of MSC-based cell therapy at this time. We also examine the underlying mechanisms of MSCs to better understand the risks of tumor initiation and propagation. Methods for MSC biodistribution are explored, as well as the pharmacokinetics and pharmacodynamics of cell therapies. We also highlight various promising technologies, such as nanotechnology, genome engineering technology, and biomimetic technology, to enhance MSC-DDS. For statistical analysis, we used analysis of variance (ANOVA), Kaplan Meier, and log-rank tests. In this work, we created a shared DDS medication distribution network using an extended enhanced optimization approach called enhanced particle swarm optimization (E-PSO). To identify the considerable untapped potential and highlight promising future research paths, we highlight the use of MSCs in gene delivery and medication, also membrane-coated MSC nanoparticles, for treatment and drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsNanoparticlesTissue DistributionDrug Delivery SystemsCytoplasm

Stichwörter der Autor:innen

drug delivery systemenhanced particle swarm optimization (E-PSO)mesenchymal stem cell (MSC)nanoparticlespharmacodynamicspharmacokinetics

Autor:innen und Institutionen

  • Department of Computer Engineering, SVKM'S NMIMS Mukesh Patel School of Technology Management and Engineering, Shirpur 425405, Maharashtra, India.
  • Department of Medical Education, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
  • Electrical and Computer Engineering, College of Engineering, Springdale, 316 Boulevard, Anderson, SC 29621, USA.
  • Radiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha 61421, Saudi Arabia.
  • BioImaging Unit, Space Research Centre, University of Leicester, Michael Atiyah Building, Leicester LE1 7RH, UK.
  • Department of Computer Science and Engineering, University Institute of Technology, Rajiv Gandhi Proudyogiki Vishwavidyalaya (Technological University of Madhya Pradesh), Bhopal 462033, Madhya Pradesh, India.

ORCID-Profile: Shubham Joshi, Sarah Allabun, Stephen Ojo, Mohammed S Alqahtani, Piyush Kumar Shukla, Mohamed Abbas

Förderung

  • Princess Nourah bint Abdulrahman University
  • King Khalid University (KKU)

Zitieren

APA

Joshi, S., Allabun, S., Ojo, S., Alqahtani, M. S., Shukla, P. K., Abbas, M., Wechtaisong, C., & Almohiy, H. M. (2023). Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles. Molecules, 28(5), 2130. https://doi.org/10.3390/molecules28052130

Vancouver

Joshi S, Allabun S, Ojo S, Alqahtani MS, Shukla PK, Abbas M, et al. Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles. Molecules. 2023;28(5):2130. doi:10.3390/molecules28052130

BibTeX
@article{Joshi2023,
  author = {Joshi, Shubham and Allabun, Sarah and Ojo, Stephen and Alqahtani, Mohammed S and Shukla, Piyush Kumar and Abbas, Mohamed and Wechtaisong, Chitapong and Almohiy, Hussain M},
  title = {Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {5},
  pages = {2130},
  doi = {10.3390/molecules28052130}
}
Kostenlos starten →